HomeCompareATGGF vs ADC

ATGGF vs ADC: Dividend Comparison 2026

ATGGF yields 5000.00% · ADC yields 4.13%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 ATGGF wins by $62217131802825.17M in total portfolio value
10 years
ATGGF
ATGGF
● Live price
5000.00%
Share price
$0.04
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$62217131802825.35M
Annual income
$59,861,980,287,378,210,000.00
Full ATGGF calculator →
ADC
Agree Realty Corporation
● Live price
4.13%
Share price
$74.97
Annual div
$3.10
5Y div CAGR
40.4%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$178.9K
Annual income
$80,797.29
Full ADC calculator →

Portfolio growth — ATGGF vs ADC

📍 ATGGF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodATGGFADC
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, ATGGF + ADC cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
ATGGF pays
ADC pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

ATGGF
Annual income on $10K today (after 15% tax)
$425,000.00/yr
After 10yr DRIP, annual income (after tax)
$50,882,683,244,271,480,000.00/yr
ADC
Annual income on $10K today (after 15% tax)
$351.36/yr
After 10yr DRIP, annual income (after tax)
$68,677.70/yr
At 15% tax rate, ATGGF beats the other by $50,882,683,244,271,410,000.00/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of ATGGF + ADC for your $10,000?

ATGGF: 50%ADC: 50%
100% ADC50/50100% ATGGF
Portfolio after 10yr
$31108565901412.77M
Annual income
$29,930,990,143,689,146,000.00/yr
Blended yield
96.21%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on ADC right now

ATGGF
No analyst data
Altman Z
34.8
Piotroski
2/9
ADC
Analyst Ratings
1
Strong
22
Buy
9
Hold
Consensus: Buy
Price Target
$81.06
+8.1% upside vs current
Range: $75.00 — $84.50
Altman Z
1.6
Piotroski
7/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

ATGGF buys
0
ADC buys
0
No recent congressional trades found for ATGGF or ADC in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricATGGFADC
Forward yield5000.00%4.13%
Annual dividend / share$2.00$3.10
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%40.4%
Portfolio after 10y$62217131802825.35M$178.9K
Annual income after 10y$59,861,980,287,378,210,000.00$80,797.29
Total dividends collected$62057786341622.61M$156.7K
Payment frequencyquarterlymonthly
SectorStockREIT

Year-by-year: ATGGF vs ADC ($10,000, DRIP)

YearATGGF PortfolioATGGF Income/yrADC PortfolioADC Income/yrGap
1← crossover$510,700$500,000.00$10,990$580.36+$499.7KATGGF
2$24,410,935$23,864,485.98$12,301$860.26+$24.40MATGGF
3$1,092,192,501$1,066,072,800.30$14,104$1,298.62+$1092.18MATGGF
4$45,746,366,951$44,577,720,975.17$16,691$2,008.16+$45746.35MATGGF
5$1,793,932,828,410$1,744,984,215,772.56$20,580$3,205.09+$1793932.81MATGGF
6$65,871,973,805,320$63,952,465,678,921.49$26,754$5,330.02+$65871973.78MATGGF
7$2,265,146,887,602,700$2,194,663,875,631,007.20$37,196$9,345.14+$2265146887.57MATGGF
8$72,954,689,148,998,180$70,530,981,979,263,280.00$56,244$17,523.09+$72954689148.94MATGGF
9$2,201,076,182,660,884,700$2,123,014,665,271,456,500.00$94,286$35,736.21+$2201076182660.79MATGGF
10$62,217,131,802,825,350,000$59,861,980,287,378,210,000.00$178,949$80,797.29+$62217131802825.17MATGGF

ATGGF vs ADC: Complete Analysis 2026

ATGGFStock

Actinogen Medical Limited, a biotechnology company, develops therapies for neurological and neuropsychiatric diseases associated with dysregulated brain cortisol in Australia. It is developing Xanamem, an inhibitor of the 11ß-HSD1 enzyme, which is in Phase 2 clinical trials that achieves target engagement in the central nervous system, Alzheimer's disease, depression with cognitive impairment, and anxiety, sleep, and behavioral problems in fragile X syndrome. The company was formerly known as Actinogen Limited and changed its name to Actinogen Medical Limited in November 2015. Actinogen Medical Limited was incorporated in 1999 and is based in Sydney, Australia.

Full ATGGF Calculator →

ADCREIT

Agree Realty Corporation is a publicly traded real estate investment trust primarily engaged in the acquisition and development of properties net leased to industry-leading retail tenants. As of September 30, 2020, the Company owned and operated a portfolio of 1,027 properties, located in 45 states and containing approximately 21.0 million square feet of gross leasable area. The Company's common stock is listed on the New York Stock Exchange under the symbol ADC.

Full ADC Calculator →
📬

Get this ATGGF vs ADC comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

ATGGF vs SCHDATGGF vs JEPIATGGF vs OATGGF vs KOATGGF vs MAINATGGF vs NNNATGGF vs EPRTATGGF vs FCPT

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.